Inventor

Ermes Vanotti

Inventor
Milan, IT

Overview

24→
Patents
1995–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes20%
A61NElectrotherapy6%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,081,622Substituted indazole derivatives active as kinase inhibitors20189,670,191'Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors'20179,616,059'Substituted indazole derivatives active as kinase inhibitors'20179,255,087'Substituted indazole derivatives active as kinase inhibitors'20169,102,662'Substituted indazole derivatives active as kinase inhibitors'20159,085,558'Substituted indazole derivatives active as kinase inhibitors'20159,056,854'Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors'20159,029,356'Substituted indazole derivatives active as kinase inhibitors'20158,906,934'Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors'20148,673,893'Substituted indazole derivatives active as kinase inhibitors'20148,658,662'Crystalline CDC7 inhibitor salts'20148,399,668'Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides'20138,299,057'Substituted indazole derivatives active as kinase inhibitors'20128,293,762'Isoquinolinopyrrolopyridinones active as kinase inhibitors'20128,263,604'Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors'20128,207,180'Tricyclic indoles and (4,5-dihydro) indoles'20127,618,982'Heteroarylpyrrolopyridinones active as kinase inhibitors'20097,371,862'Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them'20087,279,575'Pyrimidylpyrrole derivatives active as kinase inhibitors'20076,369,096'Benzyloxy prodigiosine compounds'20025,912,263'Taxane derivatives'19995,767,282'Method for the preparation of taxol and its derivatives'19985,719,177'Taxane derivatives'19985,470,858'Derivatives of (hetero)aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2018Based in Milan, IT· patent location history
2009–2018Patents assigned to NERVIANO MEDICAL SCIENCES SRL (16)· patent assignee history
2012–2014Patents assigned to VANOTTI ERMES (8)· patent assignee history
2012–2014Patents assigned to MENICHINCHERI MARIA (6)· patent assignee history
2012–2014Patents assigned to SCOLARO ALESSANDRA (4)· patent assignee history
2012–2014Patents assigned to CALDARELLI MARINA (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NERVIANO MEDICAL SCIENCES SRL162009–2018
VANOTTI ERMESself82012–2014
MENICHINCHERI MARIA62012–2014
SCOLARO ALESSANDRA42012–2014
CALDARELLI MARINA32012–2014
Locations
LocationPatentsSpan
Milan, IT241995–2018